Emsogen | Search results | NICE

Your search for Emsogen returned no results
Showing 1 to 5 of 5 results for ennogen

Sort by

Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]
In development Reference number: GID-TA10994 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after 2 or more systemic treatments (review of TA987) [ID6619]
In development Reference number: GID-TA11823 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
In development Reference number: GID-TA11096 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Upadacitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3733]
Discontinued Reference number: GID-TA10597
Result type
Technology appraisal guidance
Status
Discontinued
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Discontinued Reference number: GID-TA10764
Result type
Technology appraisal guidance
Status
Discontinued